- Home
- ACR vs SGHT Comparison
ACR vs SGHT Comparison
Compare ACR & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACR
- SGHT
- Stock Information
- Founded
- ACR 2005
- SGHT 2011
- Country
- ACR United States
- SGHT United States
- Employees
- ACR N/A
- SGHT N/A
- Industry
- ACR Real Estate Investment Trusts
- SGHT Medical Specialities
- Sector
- ACR Real Estate
- SGHT Health Care
- Exchange
- ACR Nasdaq
- SGHT Nasdaq
- Market Cap
- ACR 142.8M
- SGHT 140.1M
- IPO Year
- ACR N/A
- SGHT 2021
- Fundamental
- Price
- ACR $19.52
- SGHT $2.53
- Analyst Decision
- ACR Buy
- SGHT Buy
- Analyst Count
- ACR 2
- SGHT 7
- Target Price
- ACR $17.50
- SGHT $4.68
- AVG Volume (30 Days)
- ACR 26.2K
- SGHT 195.9K
- Earning Date
- ACR 03-05-2025
- SGHT 03-05-2025
- Dividend Yield
- ACR N/A
- SGHT N/A
- EPS Growth
- ACR N/A
- SGHT N/A
- EPS
- ACR 0.83
- SGHT N/A
- Revenue
- ACR $77,437,000.00
- SGHT $79,543,000.00
- Revenue This Year
- ACR N/A
- SGHT $1.23
- Revenue Next Year
- ACR N/A
- SGHT $0.34
- P/E Ratio
- ACR $23.46
- SGHT N/A
- Revenue Growth
- ACR 8.77
- SGHT N/A
- 52 Week Low
- ACR $10.34
- SGHT $2.50
- 52 Week High
- ACR $20.00
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- ACR 66.84
- SGHT 35.62
- Support Level
- ACR $18.67
- SGHT $2.59
- Resistance Level
- ACR $20.00
- SGHT $2.87
- Average True Range (ATR)
- ACR 0.50
- SGHT 0.18
- MACD
- ACR 0.09
- SGHT 0.02
- Stochastic Oscillator
- ACR 82.48
- SGHT 6.74
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.